Podcasts about Melanoma

In this eye-opening episode with Nadine Artemis, author of Renegade Beauty and Holistic Dental Care, we challenge everything you thought you knew about the sun. She unpacks why sunlight has become so controversial, tracing the history of heliotherapy and the very real biological need humans have for natural light. Nadine dives into the surprising benefits of sun exposure even in the winter, how light entering the eyes affects our hormones, and what the melanoma research actually shows when you look beyond the headlines. The conversation takes a bold turn as she exposes the real issues with modern sunscreen, explores vitamin D–rich foods in cold climates, and explains the deep connection between sunlight, bone health, and strong teeth. We also discuss tanning beds, the melanotan peptide, melatonin as a form of internal sun protection, and what our skin was truly designed to do. Packed with practical daily sun and light guidance, this episode will completely reshape how you think about sunshine, skin health, and long-term vitality. Nadine Artemis, the author of Renegade Beauty and Holistic Dental Care, is the creator of Living Libations, a pure and luxurious line of organic oral care, botanical beauty care, and medicinal elixirs often called the “holy grail” of wholesome skincare. Artemis is an innovative aromacologist, and her healing formulations and her concept of renegade beauty encourage effortlessness, engaging with the elements, and inspires people to rethink conventional notions of wellness and beauty. She is a key speaker at health and wellness conferences and has received glowing reviews in the Hollywood Reporter, GOOP, Vogue, People, Elle, Yoga Journal, Natural Health, W Magazine, The New York Times, Forbes, Los Angeles Times, and National Post.SHOW NOTES:0:40 Welcome to the podcast!2:49 About Nadine Artemis3:23 Welcome her to the show!5:36 Why is the sun so polarizing?8:06 History and research on heliotherapy11:29 Biological need for sun's rays13:17 Benefits of the sun in the winter16:52 Sunglasses & light in your eyes17:11 Melanoma study18:59 The real problem with sunscreen21:45 Vitamin D foods in cold climates24:30 Bone health & teeth25:57 *ELLIE MD*27:46 Tanning & Melanotan32:39 Melatonin as sun protection38:41 Protecting your face44:12 What our skin is designed for46:42 Daily sun & light advice53:45 Her final piece of advice54:40 Living Libations55:54 Thanks for tuning in!RESOURCES:ELLIE MD PeptidesFollow Nadine:Website: https://livinglibations.comIG: @nadineartemisofficial / @livinglibationsofficial Facebook: @LivingLibations @nadineartemisofficial Twitter/X / @LivingLibationsBook: Myth on MythSperti Vitamin D Lamp - 10% off with code: BIOHACKERBABESDMinder AppSunHugg - 10% off with code: BIOHACKERBABESBiolongevity Labs (Melanotan Peptide) - Discount code: BIOHACKERBABESSupport this podcast at — https://redcircle.com/biohacker-babes-podcast/donationsAdvertising Inquiries: https://redcircle.com/brands

To have Dr. Morse answer a question, visit: https://drmorses.tv/ask/ All of Dr. Morse's and his son's websites under one roof: https://handcrafted.health/ Facebook Page: https://www.facebook.com/handcrafted.health 00:00:00 - Intro - Health - The Medical World - and much more! 00:29:18 - Accutane - Update - Eye Pictures 00:52:05 - Blood Sugar 00:59:39 - Stage 3 Melanoma Cancer - Thyroid Cancer 01:43:30 - Anxiety and Panic attacks - Lethargic - Lack of Periods - Low Blood Pressure - Constipation 01:59:35 - Seed oils 02:03:38 - Conception  00:29:18 - Accutane - Update - Eye Pictures After a week of doing the diet and herbs, my life did a complete 180, it was the craziest experience ever! 00:52:05 - Blood Sugar I have a question about being on an all-fruit /vegetable diet. 00:59:39 - Stage 3 Melanoma Cancer - Thyroid Cancer They cut out her entire thyroid and I think the parathyroids too.  01:43:30 - Anxiety and Panic attacks - Lethargic - Lack of Periods - Low Blood Pressure - Constipation Do antidepressants cause you to get worse?  01:59:35 - Seed oils Do you agree that seed oils are some of the worst things you can eat? 02:03:38 - Conception  In the past 4 years I've tried many different things in order to conceive, nothing seems to be working.

Melanoma survivor Leah Koskinen joins me to break down what every family needs to know about sun safety. We talk about the real risks behind sunburns and tanning, how to spot concerning moles early, and why year-round protection matters more than most people realize. Leah also shares practical, mom-friendly strategies for choosing sunscreen, using UPF clothing, and getting enough vitamin D without damaging your skin. Click HERE to access the show notes for this episode. 

New Zealand has the world's highest melanoma death rate, but University of Auckland scientists hope a $1 million grant will help bring a new treatment to patient trials in just over five years. Associate Professor of Pharmacology Stephen Jamieson spoke to Lauren Crimp.

Join Dr. Martin in today's episode of The Doctor Is In Podcast.  

When it comes to your pet's health, there is no word more terrifying than "cancer." The immediate reaction is often fear, followed by a difficult question: "I wouldn't put myself through chemo, so why would I put my dog through it?"In this episode, we sit down with Dr. Rance Gamblin, a veterinary oncologist formerly at Metropolitan Veterinary Hospital and now professor at Mississippi State College of Veterinary Medicine with 24+ years of experience and a calming presence that could soothe even the most "OCD" pet parent (just ask Alice!). Dr. Gamblin helps us navigate the emotional and medical complexities of a cancer diagnosis, explaining why veterinary oncology is often far more compassionate and focused on quality of life than human medicine.In this episode, we discuss:- The "Quality of Life" Philosophy: Why the goals of pet oncology differ from human oncology—focusing on making pets feel better for longer, rather than "curing at any cost."- Common Culprits: A look at the most frequent cancers Dr. Gamblin treats, including Lymphoma, Mast Cell Tumors, and Osteosarcoma.- The Truth About Side Effects: Do dogs lose their hair? Dr. Gamblin shares the reality of how pets handle chemotherapy (hint: there's a lot more tail-wagging involved than you'd think).- Treatment Innovations: Insights into the Yale vaccine study and the fascinating science behind the Melanoma vaccine. -Proactive Pet Parenting: Why Dr. Gamblin's biggest pet peeve is the "let's just watch it" approach, and why your pet's breath or a quick rectal exam could be a lifesaver.- Knowing When It's Time: A heart-to-heart on the "Big Four" indicators of quality of life and how to navigate the toughest decision a pet owner can make.Dr. Rance Gamblin earned his BS in Biology from Mississippi State and completed his residency in Oncology and Hematology at The Ohio State University. For over two decades, he has been a pillar of the veterinary community at Metropolitan Veterinary Hospital, known for his expertise, his steady hand, and an accent you'll just have to hear for yourself to guess where he's from! He is currently a professor at Mississippi State College of Veterinary Medicine.--What started during the COVID-19 lockdown with one baby gorilla at the Cleveland Zoo has grown into a channel loved by animal fans around the world. I'm a one-person operation—filming, editing, narrating, and sharing the most heartfelt moments of baby gorillas, orangutans, elephants, and other zoo animals. Whether it's Jameela's emotional journey or Clementine's first steps, each video brings you closer to the animals and their stories. If you love watching real animal behavior, learning fun facts, and supporting conservation through storytelling—this is your place! Subscribe to Larry's Animal Safari on YouTube @larrysanimalsafari ---Support our sponsor for this episode Blue Buffalo by visiting bluebuffalo.com. BLUE Natural Veterinary Diet formulas offer the natural alternative in nutritional therapy. At Blue Buffalo, we have an in-house Research & Development (R&D) team with over 300 years' experience in well-pet and veterinary therapeutic diets, over 600 scientific publications, and over 50 U.S. patents. At Blue Buffalo, we have an in-house Research & Development (R&D) team with over 300 years' experience in well-pet and veterinary therapeutic diets, over 600 scientific publications, and over 50 U.S. patents.---All footage is owned by SLA Video Productions.

Researchers evaluated the efficacy and outcomes of complete surgical excision of perianal melanomas from 59 horses. Read the full article here: https://equimanagement.com/research-medical/research/treatment-outcomes-for-perianal-melanoma-removal-in-horses/Mentioned in this episode:EquiManagement on Audio All the articles you have come to love in EquiManagement Magazine are now available in this podcast for free. Each article is released as its own separate episode to make them quick and easy to listen to. EquiManagement always has the latest insights on equine health, veterinary practice management, and veterinarian wellness.

Dr. Lisa Duhaime is a board-certified medical oncologist at Peeples Cancer Institute at Hamilton Medical Center in Dalton, Georgia.For more information about Peeples Cancer Institute, call 844-PCI-HOPE or visit VitruvianHealth.com/cancer.This program in no way seeks to diagnose or treat illness or to replace professional medical care. Please see your healthcare provider if you have a health problem.

Australia has the highest melanoma rates in the world, and with around seventy per cent of melanomas appearing on highly visible areas like the face, head and neck, many patients' needing life-saving cancer surgery, are left with initial disfigurement as well as impaired vision, breathing, speech or facial movement after. Reconstructive procedures are critical to restoring these essential functions, from blinking to protect the eye, to nasal airflow for breathing, and facial movement for speech and expression.

La Dra. Lisa Duhaime es oncóloga médica certificada por la junta del Peeples Cancer Institute en Dalton, Georgia.Para obtener más información sobre Peeples Cancer Institute, llame al 844-PCI-HOPE o visite VitruvianHealth.com/cancer.Este podcast de ninguna manera busca diagnosticar o tratar enfermedades o reemplazar la atención médica profesional. Consulte a su proveedor de atención médica si tiene un problema de salud. La versión en español es una traducción del original en inglés. En caso de discrepancia, prevalecerá el original en inglés (Health for Life: https://health-for-life.captivate.fm/listen).This program in no way seeks to diagnose or treat illness or to replace professional medical care. Please see your healthcare provider if you have a health problem. The Spanish version is a translation of the original in English. In case of a discrepancy, the English original (Health for Life: https://health-for-life.captivate.fm/listen) will prevail.

A stage-IV metastatic melanoma diagnosis is often delivered with words like incurable and life-limiting. In this deeply moving episode, Dr. Michael Karlfeldt sits down with Kevin Donaghy, an IT consultant from Melrose, Scotland, who has lived more than six years beyond his diagnosis—and transformed his personal cancer journey into a global mission of hope. Through his lived experience and the revolutionary impact of immunotherapy, Kevin offers rare insight into what it truly means to navigate advanced cancer with courage, honesty, and humanity.Kevin shares the emotional realities of being told his cancer was medically incurable, the isolation and fear that followed, and how finding community during COVID lockdowns became a turning point for his mental health. Out of that connection grew Stories of Cancer and Hope, an anthology of 39 real-life cancer stories—some triumphant, some heartbreaking—all designed to offer solidarity to those who feel alone. Listeners will hear powerful reflections on cancer ghosting, mental health struggles, redefining hope, and why shared stories can be as life-saving as treatment itself.This episode is essential listening for cancer patients, survivors, caregivers, and healthcare professionals alike. Whether you are newly diagnosed, supporting a loved one, or seeking deeper understanding of the emotional side of cancer, Kevin's story reminds us that hope is not a single outcome—it is something that evolves, connects, and endures.Key Topics CoveredLiving beyond a stage-IV metastatic melanoma diagnosisThe emotional shock of being told cancer is “incurable”Immunotherapy for melanoma: promise, risks, and realitiesCancer isolation, loneliness, and “cancer ghosting”Mental health challenges and suicidal ideation in cancer patientsThe healing power of community and shared lived experienceCreating Stories of Cancer and Hope and distributing thousands of free booksHow hope changes throughout the cancer journeySupporting families and caregivers through understanding and empathyConnect with Kevin Donaghy & Stories of Cancer and HopeWebsite: https://www.storiesofcancerandhope.co.uk/Social Media:LinkedIn: Kevin DonaghyInstagram: Kevin A Donaghy, Stories of Cancer and HopeBluesky: storiescancerhope.bsky.socialAmazon Author Page: https://www.amazon.com/stores/Kevin-Donaghy/author/B0D7S7LRMJ?ref=ap_rdr&shoppingPortalEnabled=true&ccs_id=d17d4d5b-3bb2-4adf-87a3-b274a0211630 -----------------------------------------------A Better Way to Treat Cancer: A Comprehensive Guide to Understanding, Preventing and Most Effectively Treating Our Biggest Health ThreatGrab my book here: https://www.amazon.com/dp/B0CM1KKD9X?ref_=pe_3052080_397514860 Unleashing 10X Power: A Revolutionary Approach to Conquering CancerGet it here: https://store.thekarlfeldtcenter.com/products/unleashing-10x-powerPrice: $24.99100% Off Discount Code: CANCERPODCAST1 Healing Within: Unraveling the Emotional Roots of CancerGet it here: https://store.thekarlfeldtcenter.com/products/healing-withinPrice: $24.99100% Off Discount Code: CANCERPODCAST2-----------------------------------------------Integrative Cancer Solutions was created to instill hope and empowerment. Other people have been where you are right now and have already done the research for you. Listen to their stories and journeys and apply what they learned to achieve similar outcomes as they have, cancer remission and an even more fullness of life than before the diagnosis. Guests will discuss what therapies, supplements, and practitioners they relied on to beat cancer. Once diagnosed, time is of the essence. This podcast will dramatically reduce your learning curve as you search for your own solution to cancer. To learn more about the cutting-edge integrative cancer therapies Dr. Karlfeldt offer at his center, please visit www.TheKarlfeldtCenter.com

Popular media leverage weak study to criticize RFK Jr.'s rethink of standard recommendations for saturated fat avoidance; Poor quality plant-based diets hike cardio risk; A listener complains his lp(a) is going up with age despite his healthy diet, lifestyle; Scientists pinpoint cocoa ingredient that slows aging; Berry proanthocyanidins preserve brain power; Tattooing may promote inflammation, undermine immunity.

Q-BANK: https://patreon.com/highyieldfamilymedicineIntro (0:35),Venous leg ulcers (1:45),Arterial (ischemic) ulcers (2:58),Diabetic foot ulcers (4:42),Pressure injuries (6:10),Pyoderma gangrenosum (8:24),Burns (9:36),Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis (13:12),Warfarin necrosis (14:33),Necrotizing fasciitis (15:21),Rocky Mountain Spotted Fever (16:22),Erythema nodosum (17:35),Lipoma (19:08),Epidermal inclusion cyst (20:00),Dermatofibroma (20:51),Cherry hemangiomas (21:52),Seborrheic ketatosis (22:37),Actinic keratosis (23:41),Basal cell carcinoma (24:47),Squamous cell carcinoma (26:24),Melanoma (28:05),Kaposi sarcoma (30:29),Mycosis fungoides (31:26),Practice questions (32:50)

Today's guest is Tessa Parry-Wingfield, global communications consultant, public speaker, and survivor of ocular melanoma, a very rare form of eye cancer that affects about 6 people per million annually. She has found purpose in her adversity and ironically "sees life clearly" despite her vision issues.We talk about learning to live with a prosthetic eye and monocular vision, the challenges of rare cancers, eye and vision health (see your eye doctor regularly), finding purpose and clarity post diagnosis, and so much more!Resources:Tessa's Website: Tessa Parry-Wingfield | Speaker + Storyteller | Seeing life clearly |Tessa's Instagram: https://www.instagram.com/seeing_life_clearly/Tessa's LinkedIn: Tessa Parry-Wingfield | LinkedInFollow:Follow me: https://www.instagram.com/melissagrosboll/My website: https://melissagrosboll.comEmail me: drmelissagrosboll@gmail.com

Commentary by Dr. Avirup Guha.

Veterinarian David Levine is a boarded surgeon who frequently deals with equine skin issues such as melanoma. Learn what melanomas are, how to recognize them, and what can be done to treat them.My Senior Horse - Episode 35 Guests and Links:Guest: Dr. David Levine, DVMConnect with Host: Kimberly S. Brown of Editorial Director of My Senior Horse | Email Kim (kbrown@equinenetwork.com) | Follow Kim on LinkedIn (@kimberlylsbrown)

Did Cankles Caligula forget he has a son with Melanoma or is "her son" just not his? MAGAT House introduces silly excuse for a healthcare bill. More photos from the Epstein Estate and the ones yet to come are described as deeply disturbing. ICE goon gets taken to police station after attempting to kidnap immigrants. Maryland court allows sexual abuse lawsuit against Linda McMahon go forward. 

This week, we discuss neuroendocrine tumours and melanoma as our ESMO 25 journey continues. Trials for neuroendocrine cancers include HIF-2 alpha inhibitors, targeted alpha therapy, and a classic anti-PD-1/TIGIT bispecific antibody combined with standard etoposide and cisplatin chemotherapies.Melanoma is once again seeking that elusive breakthrough: the second-line therapy that demonstrates immunotherapy is not a one-time opportunity. We also highlight both the BNT111 RNA-based lipoplex immunotherapy targeting agent and the question of whether early discontinuation of immunotherapy could be beneficial.Studies:LITESPARK-15IMPRESS-Norway trialAbstract 1510M0BNT111 (NCT04526899)Safe Stop TrialFor more episodes, resources and blog posts, visit www.inquisitiveonc.comPlease find us on Twitter @InquisitiveOnc!If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.comArt courtesy of Taryn SilverMusic courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer, Gilead Pharmaceuticals and Merck Pharmaceuticals. MSD provided virtual participation with ESMO. Our partners have access to the episode at the same time you do and have no editorial control over the content. Hosted on Acast. See acast.com/privacy for more information.

Melanoma used to have almost no effective treatment options. Now? Immunotherapy is changing lives — and Oxford's Dr. Mark Middleton joins us to unpack the science, the turning points, and the innovations reshaping melanoma care.In this episode, he reflects on decades of research — from the early trials that taught researchers what not to do, to the breakthroughs in checkpoint inhibition and precision approaches that dramatically improved outcomes. We also dive into MyMelanoma, a nationwide effort gathering real-world patient data to answer questions traditional trials often leave behind.Takeaways:What researchers learned from early immunotherapy trial failures — and how those lessons shaped today's strategies The evolving science behind checkpoint inhibitors and why certain patients respond more durably than othersHow MyMelanoma is uncovering insights on risk, survivorship, lifestyle factors, and real-world outcomes at scale The future of melanoma treatment, including biomarkers, combinatorial approaches, and better trial designs

Does having darker skin really protect you from skin cancer? Can you imagine getting a Pap smear every single day for 21 years just to help your husband’s research? And, what do you do if your vagina involuntarily “clenches” during sex. In this episode, we speak to Professor Georgina Long, Medical Director of Melanoma Institute Australia (MIA) and 2024 Australian of the Year, to decode Australia’s complicated relationship with the sun. We talk about the "ABCDE" rule for checking your moles, whether darker skin tones are at less risk of melanoma and why you should be taking photos of your skin spots.Plus, in Med School, Claire and Dr Mariam pay tribute to the unsung heroines of medical history - from the wife of Dr. Papanicolaou (who underwent daily pap smears for 21 years ) to Anarcha Westcott, the enslaved woman known as the 'mother of modern gynecology', who endured 30 experimental surgeries without anaesthesia.And, in our Quick Consult, Dr Mariam helps a listener named Sarah who is struggling with Vaginismus. We break down exactly what this condition is, why it is a physical reflex rather than "just in your head" and the multidisciplinary team you need to help reclaim your sex life.THE END BITS All your health information is in the Well Hub. If you've been putting off a skin check, this is your sign to book it. For more information on sun safety, visit the Cancer Council. We understand that conversations about cancer can be difficult, whether you're navigating your own diagnosis, supporting a loved one, or remembering someone you've lost. If today's episode has brought up difficult feelings, please reach out. The Cancer Council offers a confidential support line staffed by specialist nurses, and you can call them on 13 11 20. For more specific information on the topics we discussed today, organisations like the Cancer Council, the Australian Skin Cancer Foundation, and the Melanoma & Skin Cancer Advocacy Network (MSCAN) provide dedicated advocacy, education and community support for patients impacted by all forms of skin cancer. And if you just need to talk to someone immediately, you can always call Lifeline on 13 11 14. Remember to be kind to yourself, and please don't hesitate to seek support. GET IN TOUCH Sign up to the Well Newsletter to receive your weekly dose of trusted health expertise without the medical jargon. Ask a question of our experts or share your story, feedback, or dilemma - you can send it anonymously here, email here or leave us a voice note here. Ask The Doc: Ask us a question in The Waiting Room. Follow us on Instagram and Tiktok. Support independent women’s media by becoming a Mamamia subscriber CREDITS Hosts: Claire Murphy and Dr Mariam Guest: Professor Georgina Long Senior Producers: Claire Murphy and Sally Best Audio Producer: Scott Stronach Video Producer: Julian Rosario Social Producer: Elly Moore Mamamia acknowledges the Traditional Owners of the Land we have recorded this podcast on, the Gadigal people of the Eora Nation. We pay our respects to their Elders past and present, and extend that respect to all Aboriginal and Torres Strait Islander cultures.Information discussed in Well. is for education purposes only and is not intended to provide professional medical advice. Listeners should seek their own medical advice, specific to their circumstances, from their treating doctor or health care professional. +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++Support the show: https://www.mamamia.com.au/mplus/See omnystudio.com/listener for privacy information.

Welcome to Session 1 of the Eye Believe Survivorship Seminar 2025! This 8:00 AM session features renowned ocular oncologist Dr. MATERIN (Duke Health) as he presents “Yesterday, Today & Tomorrow in Ocular Melanoma.” In this powerful opening session, Dr. Materin walks attendees through:

In this episode, we sit down with Vanessa Tompkins, wife and caregiver to Mike, who has been battling Stage 4 metastasized ocular melanoma. Over the past five years, Vanessa has supported Mike through weekly immunotherapy, four major surgeries—including the removal of his left eye, liver surgery, triple hernia repair, and open-heart surgery—and countless challenges along the way.A registered nurse, former hospice nurse, and current Sexual Assault Forensic Examiner, Vanessa brings professional expertise, personal experience, and unwavering compassion to her role as a caregiver. She is also a mother of three, grandmother of four, and devoted owner of her golden lab, Romeo. Guided by her motto, “One day at a time,” Vanessa shares insights into the realities of caregiving, the emotional resilience required, and the lessons learned in supporting a loved one through a complex and ongoing cancer journey.Tune in to hear her story, practical tips, and heartfelt reflections on the challenges and rewards of being a caregiver.

In this episode, we interview Danny Powell, an ocular melanoma (OM) patient whose tumor was identified early thanks to his eye doctor noticing a change and acting quickly. Danny explains his diagnosis, his treatment with brachytherapy, and how he later discovered that his grandmother also had OM—an extremely rare family connection. This prompted genetic testing, which revealed that Danny carries a BAP1 gene mutation. He discusses what that means for his ongoing care, his decision to join a clinical study, and the importance of regular surveillance scans. Whether you're an OM patient, caregiver, or medical professional, this episode provides practical insight into early detection, genetic risk factors, and patient involvement in research.

TJ Sharpe is a stage four melanoma survivor, nationally known patient advocate, keynote speaker, digital health technologist, and consultant to the life sciences industry. Drawing from personal experience and his work in clinical research, TJ empowers healthcare and pharma organizations to prioritize patient-centric approaches to trials, communication, and support. He shares his story to inspire others facing adversity and to promote transformative improvements in healthcare. In this episode of Marketer of the Day, TJ Sharpe joins Robert Plank to recount his journey from being diagnosed with melanoma in his twenties, through a life-threatening recurrence that led him to cutting-edge clinical trials, to his eventual recovery and the launch of his advocacy career. TJ details his navigation of the medical system, the emotional and logistical challenges faced by patients, and how gratitude and support systems are as important as medical interventions. The discussion spotlights the importance of accessible, transparent information, and patient empowerment within clinical research. TJ also describes his consulting work to help organizations incorporate patient voices and streamline drug development for the benefit of all. Quotes: “If you don't know all your options, you're not making the most informed choice for you.” “Finding your ‘ninja'—that support person—makes all the difference in getting through a cancer journey.” “It's not just about surviving cancer, it's about making a difference for millions more who will walk this path.” Resources: Visit TJ Sharpe's Website Connect with TJ Sharpe on LinkedIn

The Naked Scientists welcome the return of a new series of Titans of Science, where the world's scientific, medical, and technological pioneers tell us about the significance of their work. Today's episode features Georgina Long, the director of the Melanoma Institute Australia, who has used groundbreaking techniques to overcome the disease. Melanoma is a type of cancer that is particularly common in Georgina's homeland, and she has been telling Chris Smith how her work has made her one of Australia's most recognisable scientists... Like this podcast? Please help us by supporting the Naked Scientists

Please visit answersincme.com/GVY860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in the treatment of melanoma discusses the clinical evidence for guideline-preferred first-line treatment options and factors informing treatment in metastatic or unresectable disease. Upon completion of this activity, participants should be better able to: Summarize efficacy and safety evidence on the guideline-preferred first-line therapies for metastatic or unresectable melanoma; and Review factors informing treatment selection among the guideline-preferred first-line therapies for patients with metastatic or unresectable melanoma.

Please visit answersincme.com/GVY860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in the treatment of melanoma discusses the clinical evidence for guideline-preferred first-line treatment options and factors informing treatment in metastatic or unresectable disease. Upon completion of this activity, participants should be better able to: Summarize efficacy and safety evidence on the guideline-preferred first-line therapies for metastatic or unresectable melanoma; and Review factors informing treatment selection among the guideline-preferred first-line therapies for patients with metastatic or unresectable melanoma.

Can natural herbs aid recovery from anorexia? What an analysis of Hitler's DNA tells us about how genes shaped his personality; Can surgical anesthesia accelerate memory loss?  Bananas could be interfering with your smoothie's health benefits; Not just sun, but pesticides and herbicides increase risk for melanoma; Chemical residues on produce impair male fertility; Proliferation of fast-paced social media videos are dumbing us down; Doctors aren't less resilient, the demands of medicine are just fostering unprecedented levels of physician burnout.

Estas son las noticias de la mañana del lunes 24 de noviembre de 2025

Please visit answersincme.com/CAY860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in melanoma discusses how to optimize the use of neoadjuvant, adjuvant, or perioperative immunotherapy approaches for patients with resectable high-risk melanoma. Upon completion of this activity, participants should be better able to: Recognize recurrence patterns in patients with resected high-risk melanoma and the importance of timely referral to improve recurrence-free survival; Evaluate the risk-benefit profiles of neoadjuvant, adjuvant, or perioperative immunotherapy in patients with resectable stage IIB/C and stage III/IV melanoma; and Outline strategies to individualize the selection of neoadjuvant, adjuvant, or perioperative immunotherapy approaches for patients with resectable stage IIB/C and stage III/IV melanoma.

Please visit answersincme.com/CAY860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in melanoma discusses how to optimize the use of neoadjuvant, adjuvant, or perioperative immunotherapy approaches for patients with resectable high-risk melanoma. Upon completion of this activity, participants should be better able to: Recognize recurrence patterns in patients with resected high-risk melanoma and the importance of timely referral to improve recurrence-free survival; Evaluate the risk-benefit profiles of neoadjuvant, adjuvant, or perioperative immunotherapy in patients with resectable stage IIB/C and stage III/IV melanoma; and Outline strategies to individualize the selection of neoadjuvant, adjuvant, or perioperative immunotherapy approaches for patients with resectable stage IIB/C and stage III/IV melanoma.

Key PointsCraig identified his lymph nodes as the most difficult area to treat after the squamous cell carcinoma metastasized into his neck and spread rapidly through his body almost overnight.Black salve treatment was used successfully on two to three dozen skin cancers over several years, with one recurring lesion in the jawline requiring multiple treatments through the soft tissue.Craig's wife noticed a suspicious mole with irregular pattern and color changes, prompting her to urge him to seek medical attention despite his reluctance to visit doctors.Inspiration came from a friend named Mick from Port Lincoln who had laser skin cancer that progressed through multiple surgeries, chemotherapy, and radiation before doctors said they would remove his cheekbone and upper jaw as a final measure.Craig maintained a positive attitude throughout treatment, stating he was confident the natural protocols would work and never feared for his life, unlike many other cancer patients.Multiple lesions appeared simultaneously after waking one night with a line running from a head lesion down to his lymph nodes, creating a half golf ball-sized mass in his neck.Internal bloodroot capsules were taken as part of the treatment protocol, causing approximately 30 lesions to emerge on his back, arms, and legs all at once several weeks later.Rick Simpson oil was consumed at a dosage of two grams daily, taken as suppositories during daytime to maintain functionality and orally before bed mixed with coconut oil for better sleep.Family members expressed resistance and concern about the alternative treatment approach, with some calling him an idiot for thinking he knew better than doctors.Cannabis access in Australia has become easier through decriminalized status in some states and a government medicinal cannabis program, with much product imported from Canada.Comprehensive detox protocols included a clean organic vegan diet with no sugar, castor oil liver detox treatments, coffee enemas, heavy metal detox smoothies with cilantro, and Essiac tea.Craig's partner's 77-year-old mother was diagnosed with stage four lung cancer that had metastasized to her heart lining, with doctors stating there was nothing they could do.Treatment for the partner's mother included Rick Simpson oil mixed with frankincense and myrrh, plus the same vegan diet and detox protocols, along with Fenbendazole and Ivermectin.Eight weeks after starting alternative treatment, scans showed the partner's mother's stage four lung cancer was nearly all gone, with only small scar tissue remaining. Visit our website: CannabisHealthRadio.comFind high-quality cannabis and CBD + get free consultations at MyFitLife.net/cannabishealthDiscover products and get expert advice from Swan ApothecaryFollow us on Facebook.Follow us on Instagram.Find us on Rumble.Keep your privacy! Buy NixT420 Odor Remover Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Visuals: https://getbehindthebillboard.com/episode-97-andy-clough-richard-mcgrannGood things come to those who wait … and we've been waiting a while for Andy Clough & Richard McGrann, but it was thoroughly worth it. Andy & Rich are one of adland's most brilliant and prolific teams, creating iconic award-winning work wherever they've worked. RKCR / Y&R, BBH, AMVBBDO, adam&eveDDB and Neverland have all benefited from their passion for big ideas, superbly executed. They've won awards wherever they've been, including 5 Grand Prix for their emotive ‘The Last Photo' campaign for CALM, placing them amongst the world's most awarded creatives at D&AD and Cannes.In a packed episode, we talked about The Times ‘Biggest For Sport' campaign and got a sneak peek into Andy's notebook and his sketches which were incredibly close to the finished work.For The Last Photo we discovered the inspiration for the big idea came in part from a Google search for ‘depression / suicide'. Every result had people sad, head in hands, in a dark place. The question was asked, what if people looked happy? Like a weight had been lifted, because they had decided to take the next step. This lead to the line ‘Suicide doesn't always look suicidal' and the concept of the last photo featuring real people. It's an incredibly moving story and a worthy follow up to the previous year's Project84 from Ant & Mike.We went into the wild with Whiskas, Feeding Your Cat's Instinct, which naturally won an outdoor Lion ;-)While for The Economist, for once we didn't discuss white headlines out of red, instead a thought provoking piece of DOOH on the subject of assisted suicide.Another important project was for Melanoma, more great crafting a simple graphic idea. And of course we found out how pot holes help create a great poster campaign for Pot Noodle.Gents, it was a total pleasure. So much amazing work for such a range of brands and projects, a tour de force in the great outdoors. Thank you so much.Thanks to our sponsorsBauer Media OutdoorView2FillSuper OptimalGAS Music

Phil L'Huillier, CEO of Scancell, has developed an off-the-shelf DNA immunotherapy designed to generate a potent and durable immune response against advanced melanoma in patients who are unresponsive to current therapies. Their lead candidate showed significant benefit when added to standard of care checkpoint inhibitors, improving duration of response without adding side effects or toxicity. Patient selection in future trials will use a blood test to identify the immune types that can be expected to respond best to the therapy. Phil explains, "Perhaps first and foremost, Scancell is a clinical-stage company developing novel active immunotherapies for patients. And our objective for patients is to pick up the patients that are unresponsive to current therapies or that respond for a short period of time to improve the overall survival through developing therapies that give a good duration of response, potent immune responses, but are also safe for patients." "Perhaps before I share results from the studies, I should step back a little bit and just tell you about the platform and the product that the data has arisen for. At Scancell, we're developing these off-the-shelf. The data that we're about to talk about comes from our lead program, which is an off-the-shelf DNA immunotherapy called Immunobody, that's the name that we use for it. And it's different from the personalized therapies, the personalized vaccines that require an individual to give a tumor sample. And then there's sequencing and manufacturing for the individual there. This is off the shelf." #Scancell #Immunobody #Immunotherapy #Cancer #Oncology #Melanoma #Biotech scancell.co.uk Download the transcript here

Phil L'Huillier, CEO of Scancell, has developed an off-the-shelf DNA immunotherapy designed to generate a potent and durable immune response against advanced melanoma in patients who are unresponsive to current therapies. Their lead candidate showed significant benefit when added to standard of care checkpoint inhibitors, improving duration of response without adding side effects or toxicity. Patient selection in future trials will use a blood test to identify the immune types that can be expected to respond best to the therapy. Phil explains, "Perhaps first and foremost, Scancell is a clinical-stage company developing novel active immunotherapies for patients. And our objective for patients is to pick up the patients that are unresponsive to current therapies or that respond for a short period of time to improve the overall survival through developing therapies that give a good duration of response, potent immune responses, but are also safe for patients." "Perhaps before I share results from the studies, I should step back a little bit and just tell you about the platform and the product that the data has arisen for. At Scancell, we're developing these off-the-shelf. The data that we're about to talk about comes from our lead program, which is an off-the-shelf DNA immunotherapy called Immunobody, that's the name that we use for it. And it's different from the personalized therapies, the personalized vaccines that require an individual to give a tumor sample. And then there's sequencing and manufacturing for the individual there. This is off the shelf." #Scancell #Immunobody #Immunotherapy #Cancer #Oncology #Melanoma #Biotech scancell.co.uk Listen to the podcast here

In this inspiring episode of the Eye Believe Podcast

Drs. Kavita Vakharia, surgical oncologist from City of Hope, Dr Sara Bateni, surgical oncologist at University of Alabama at Birmingham, Dr Nikhil Khushalanai, medical oncologist at the H. Lee Moffitt Cancer Center and James Jakub, surgical oncologist at the Mayo Clinic, Florida, discuss their current practice regarding multidisciplinary management of melanoma with a focus on the role of adjuvant systemic therapy for stages IIB, IIC and IIIA disease.

It started with a routine checkup, then she heard the word “cancer.” We follow one woman's journey who was diagnosed with breast cancer and then melanoma. 

In this episode of Beyond the Clinic: Living Well with Melanoma, Dr. Samantha Siegel is joined by Katie Ostrovsky and Cheryl Marker from the MelaHomies community.Cheryl, diagnosed with Stage I melanoma in 2023, shares how she turned to online groups for education and support when her medical team left her with more questions than answers. Katie, a Stage IV survivor now, 11 years cancer-free, reflects on the emotional and practical challenges of survivorship — and how building the Mela Homies helped transform isolation into connection.Together, they explore the power of peer support, the gaps in survivorship care, and why community is just as vital as treatment.

Skin cancer can be aggressive, and it doesn't always stay on the surface. Hear one woman's powerful story of choosing surgery and immunotherapy to fight back.

Redheads are bullied, fetishized, and medically misunderstood. Jessica Wynn is here to color in the facts about being a ginger on this Skeptical Sunday!Welcome to Skeptical Sunday, a special edition of The Jordan Harbinger Show where Jordan and a guest break down a topic that you may have never thought about, open things up, and debunk common misconceptions. This time around, we're joined by writer and researcher Jessica Wynn!Full show notes and resources can be found here: jordanharbinger.com/1219On This Week's Skeptical Sunday:The MC1R gene mutation causes red hair, pale skin, and freckles, but also influences pain processing, drug metabolism, and other biological functions throughout the body.Redheads experience pain differently — they tolerate electric shocks better but are more sensitive to heat and cold, requiring adjusted medical treatment approaches.Redheads have significantly higher melanoma risk because they produce less protective melanin, making sunscreen essential and frequent sun exposure dangerous.Redheads face ongoing discrimination and fetishization — from childhood bullying to adult harassment — despite red hair being a normal genetic variation affecting one to two percent of the population.Research on redheads' unique genetics is advancing pain treatment for everyone. Understanding genetic diversity helps medicine better serve all patients, not just those with red hair.Connect with Jordan on Twitter, Instagram, and YouTube. If you have something you'd like us to tackle here on Skeptical Sunday, drop Jordan a line at jordan@jordanharbinger.com and let him know!Connect with Jessica Wynn at Instagram and Threads, and subscribe to her newsletters: Between the Lines and Where the Shadows Linger!And if you're still game to support us, please leave a review here — even one sentence helps! Sign up for Six-Minute Networking — our free networking and relationship development mini course — at jordanharbinger.com/course!Subscribe to our once-a-week Wee Bit Wiser newsletter today and start filling your Wednesdays with wisdom!Do you even Reddit, bro? Join us at r/JordanHarbinger!This Episode Is Brought To You By Our Fine Sponsors:SimpliSafe: 50% off + 1st month free: simplisafe.com/jordanAirbnb: airbnb.com/hostApretude: Apretude.com or call 1-888-240-034Quiltmind: Email jordanaudience@quiltmind.com to get started or visit quiltmind.com for more infoWhat Was That Like: Listen here or wherever you find fine podcasts!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In today's episode of Barbell Shrugged, Anders, Doug, and Travis dive into Coach Travis' recent melanoma diagnosis, how he found out about it, and his recent surgery to eliminate it. We also dive into Anders' quest to build a gym in the middle of the woods where he plans on lifting giant trees and the latest in strength tech with Travis Mash. Work With Us: Arétē by RAPID Health Optimization Links: Anders Varner on Instagram Doug Larson on Instagram Coach Travis Mash on Instagram

In this episode of the Oncology Brothers podcast, we are joined by Dr. Omid Hamid, a melanoma specialist from Cedars-Sinai, to explore the current treatment landscape of cutaneous melanoma. We covered a wide range of topics, including: •⁠  ⁠The standard of care for early-stage melanoma, including wide local excision and sentinel lymph node evaluation. •⁠  ⁠The role of adjuvant immunotherapy and BRAF/MEK inhibitors for high-risk patients. •⁠  ⁠Insights into neoadjuvant treatment options for resectable disease, including recent trial data from NADINA and SWOG S1808. •⁠  ⁠The importance of next-generation sequencing (NGS) and circulating tumor DNA (ctDNA) in treatment planning and monitoring. •⁠  ⁠The evolving treatment paradigm for metastatic melanoma, including the use of dual checkpoint inhibitors and BRAF/MEK inhibitors. Join us as we discuss the latest advancements in melanoma treatment and the critical role of patient education and shared decision-making in oncology care. Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Don't forget to subscribe for more episodes on treatment algorithms, new FDA approvals, and conference highlights! #Melanoma #Immunotherapy #BRAF #ctDNA #Neoadjuvant #OncologyBrothers

No one's buying ABC's excuse about canning Jimmy Kimmel any more than anyone is buying Kash Patel's "Tyler Robinson text messages." Both are equally absurd. Nitwit Nero gets a very special salute in a royal review.  Melanoma, meanwhile is just . . . weird in her Grim Reaper getup. Was she rehearsing wearing widow's weeds? CNN provides a mixed bag on Jimmy Kimmel. There was almost some scant journalism. 

On today's Unemployable, we tackle the hard stuff: why cancer remains our biggest health challenge, why water quality may define the next global conflict, how outbreaks re-enter the U.S. (measles, dengue, bioterror), what COVID actually taught us, and where AI and genomics help—or create new risks. Along the way we talk access to care, compounding vs. brand-name drugs, GLP-1s (Ozempic/Wegovy), and the habits that really move the needle: sleep, strength, hydration, and walking with purpose. My guest is a former U.S. Assistant Secretary for Health and four-star admiral in the U.S. Public Health Service with leadership roles spanning MD Anderson's Moon Shots, WHO, and federal response teams for anthrax and Ebola. It's a masterclass in population health, plain talk, and what leaders should actually do next. Timestamps below. If this helps you think clearer and lead better, hit subscribe and share it with one person who needs it today. Disclaimers: This show is educational only. Nothing here is medical advice. Talk to your doctor before making decisions about screening, vaccines, medications, or treatment. Resources mentioned: • Joxel Garcia's books on Amazon • St. Jude Children's Research Hospital • MD Anderson Moon Shots • CDC/WHO resources on vaccines & outbreaks 

On today's Unemployable, we tackle the hard stuff: why cancer remains our biggest health challenge, why water quality may define the next global conflict, how outbreaks re-enter the U.S. (measles, dengue, bioterror), what COVID actually taught us, and where AI and genomics help—or create new risks. Along the way we talk access to care, compounding vs. brand-name drugs, GLP-1s (Ozempic/Wegovy), and the habits that really move the needle: sleep, strength, hydration, and walking with purpose. My guest is a former U.S. Assistant Secretary for Health and four-star admiral in the U.S. Public Health Service with leadership roles spanning MD Anderson's Moon Shots, WHO, and federal response teams for anthrax and Ebola. It's a masterclass in population health, plain talk, and what leaders should actually do next. Timestamps below. If this helps you think clearer and lead better, hit subscribe and share it with one person who needs it today. Disclaimers: This show is educational only. Nothing here is medical advice. Talk to your doctor before making decisions about screening, vaccines, medications, or treatment. Resources mentioned: • Joxel Garcia's books on Amazon • St. Jude Children's Research Hospital • MD Anderson Moon Shots • CDC/WHO resources on vaccines & outbreaks 

The incidence and prevalence of cutaneous melanoma in the US and worldwide have increased over the last 5 decades. JAMA Review Author John Kirkwood, MD, discusses the epidemiology, risk factors, treatment, and prevention of melanoma with JAMA Deputy Editor Kristin Walter, MD, MS. Related Content: Cutaneous Melanoma ----------------------------------- JAMA Editors' Summary